• Thumbnail for Daratumumab
    Daratumumab, sold under the brand name Darzalex among others, is an anti-cancer monoclonal antibody medication. It binds to CD38, which is overexpressed...
    22 KB (1,836 words) - 05:53, 21 September 2024
  • Daratumumab/hyaluronidase, sold under the brand name Darzalex Faspro, is a fixed-dose combination medication for the treatment of adults with newly diagnosed...
    11 KB (954 words) - 06:56, 8 August 2024
  • cyclophosphamide, bortezomib and dexamethasone (CyBorD) with daratumumab added. Daratumumab, a monoclonal antibody to CD38, a protein that is expressed...
    16 KB (1,638 words) - 20:43, 24 September 2024
  • Thumbnail for Antibody-dependent cellular cytotoxicity
    vitro during trastuzumab treatment. Multiple myeloma can be treated with daratumumab (Darzalex) monoclonal antibody. Studies with in vitro materials and patient...
    13 KB (1,661 words) - 22:18, 9 December 2023
  • Thumbnail for CD38
    marker in leukemia. Daratumumab (Darzalex) which targets CD38 has been used in treating multiple myeloma. The use of Daratumumab can interfere with pre-blood...
    35 KB (3,825 words) - 04:52, 10 September 2024
  • cancer (Seagen) Marketed by partners: Darzalex (IV) (daratumumab) / Darzalex Faspro (SC) (daratumumab and hyaluronidase) for the treatment of all stages...
    26 KB (1,906 words) - 04:10, 19 June 2024
  • Thumbnail for Hyaluronidase
    (Rituxan Hycela), trastuzumab/hyaluronidase-oysk (Herceptin Hylecta), daratumumab/hyaluronidase-fihj (Darzalex Faspro), and pertuzumab/trastuzumab/hyaluronidase–zzxf...
    34 KB (3,092 words) - 05:38, 14 September 2024
  • Thumbnail for Multiple myeloma
    groupings include one or more of a monoclonal antibody (e.g., isatuximab or daratumumab), an immunomodulatory agent (e.g., lenalidomide or pomalidomide), and...
    131 KB (13,506 words) - 14:34, 29 September 2024
  • 1007/978-3-540-47648-1_1505. ISBN 978-3-540-36847-2. "Summary of opinion: Darzalex,daratumumab". Case Medical Research. 2019-12-13. doi:10.31525/cmr-242ed13. ISSN 2643-4652...
    25 KB (1,860 words) - 04:49, 26 July 2024
  • Thumbnail for Isatuximab
    daratumumab is in the recognition of the different amino acid groups. Isatuximab identifies 23 amino acids of CD38 to the contrary with daratumumab who...
    31 KB (3,186 words) - 02:41, 16 July 2024